Biotech

All articles by Biotech

How did I get here: Calliditas Therapeutics’ Andy Udell
How did I get here: Calliditas Therapeutics’ Andy Udell
MM+M Staff
December 5, 2022
12:00 pm

Udell cuts a unique figure within the world of pharma leadership for a bunch of reasons. Here, he talks pandemic takeaways and a life lesson gleaned from Tommy Boy.

Seagen turns to Novartis Oncology vet David Epstein as permanent CEO
Seagen turns to Novartis Oncology vet David Epstein as permanent CEO
Marc Iskowitz
November 10, 2022
12:50 pm

The Novartis Oncology vet was one of two big-name hires Thursday to hail from a post-CEO biotech investment firm role.

Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Jack O'Brien
November 10, 2022
9:40 am

Viehbacher replaces outgoing CEO Michel Vounatsos, who had led the company since 2017.

ImmunoGen commercial chief to withdraw before drug launch
ImmunoGen commercial chief to withdraw before drug launch
Marc Iskowitz
November 4, 2022
9:31 am

The executive is leaving just prior to a scheduled regulatory decision on the biotech’s lead asset.

Odyssey Therapeutics CEO outlines $168M Series B round
Odyssey Therapeutics CEO outlines $168M Series B round
Jack O'Brien
October 31, 2022
3:35 pm

The financing round was led by General Catalyst and seeks to boost the company’s precision immunomodulators and oncology medicines.

Despite late surge from legacy brands, Biogen looks to lecanemab
Despite late surge from legacy brands, Biogen looks to lecanemab
Marc Iskowitz
October 26, 2022
10:21 am

The biotech could be sitting on a commercial success with Alzheimer’s prospect lecanemab, but it can’t afford a repeat of past errors.

Biotech employees’ desire for freedom and flexibility is ‘here to stay,’ survey finds
Biotech employees’ desire for freedom and flexibility is ‘here to stay,’ survey finds
Lecia Bushak
October 20, 2022
3:31 pm

A recent Singular Talent survey digs into the motivations and desires among biotech employees as well as what employers can do to maintain retention.

Versant-backed Nested Therapeutics takes off with $125M in financing
Versant-backed Nested Therapeutics takes off with $125M in financing
Jack O'Brien
October 6, 2022
1:49 pm

Nested is led by CEO Darrin Miles, who previously worked as chief commercial officer at Agios Pharmaceuticals.

Genentech aims to boost interest in biotech careers with Futurelab+ educational initiative
Genentech aims to boost interest in biotech careers with Futurelab+ educational initiative
Jack O'Brien
October 4, 2022
12:30 pm

The $10 million expansion is centered on supporting STEM education and biotech careers in schools in South San Francisco and beyond.

Prime Global buys creative digital agency Earthware
Prime Global buys creative digital agency Earthware
Jack O'Brien
September 30, 2022
11:08 am

This is the second major acquisition for Prime Global since it partnered with Levine Leichtman Capital Partners in April 2021.

  • From Our Partners